Key Takeaways
- • Truehelm, formerly TT Capital Partners, has been named to Inc.'s 2026 Founder-Friendly Investors list for the fifth consecutive year, placing it among a select group of firms recognized for five straight years.
- • The healthcare private equity firm invests exclusively in healthcare IT and tech-enabled services businesses.
- • The Inc. recognition is based on feedback from founders and business leaders who have worked with investment firms, evaluating trust, alignment and post-investment support.
- • CEO Dawn Owens attributes the recognition to a sustained commitment to founders building healthcare companies, while CollabDocs CEO Mike Morgan credits the firm's industry knowledge and operational rigor.
Summary
Truehelm, a healthcare private equity firm formerly known as TT Capital Partners, announced from Minneapolis that it has been named to Inc.'s 2026 Founder-Friendly Investors list. The recognition marks the fifth consecutive year the firm has been included, placing it among a select group of firms nationwide honored for five straight years, according to the company's press release distributed via Business Wire.
Inc.'s Founder-Friendly Investors program identifies private equity, venture capital and debt firms with established records of supporting entrepreneurs and founder-led organizations. The annual selection process incorporates direct feedback from business leaders and founders who have partnered with investment firms, evaluating factors including trust, alignment and post-investment support.
Truehelm invests exclusively in healthcare IT and tech-enabled services businesses, partnering with founders and management teams to accelerate growth. The firm describes its approach as combining investment expertise with healthcare operational acumen and a collaborative partnership model, providing strategic guidance, operational support, resources and talent to portfolio companies.
Mike Morgan, CEO of Truehelm portfolio company CollabDocs and former CEO of exited portfolio company Updox, said the firm brings "the industry knowledge, strategic insight, and operational rigor necessary to drive sustainable growth." Truehelm CEO and Partner Dawn Owens said the firm remains committed to supporting founders building healthcare companies and is honored by the trust its partners place in it.
The announcement is one of several recent Inc. Founder-Friendly Investors recognitions issued through Business Wire, including releases from FTV Capital, Nonantum Capital Partners and Hildred. The press release does not disclose fund size, deal values or assets under management.
Inc.'s Founder-Friendly Investors program identifies private equity, venture capital and debt firms with established records of supporting entrepreneurs and founder-led organizations. The annual selection process incorporates direct feedback from business leaders and founders who have partnered with investment firms, evaluating factors including trust, alignment and post-investment support.
Truehelm invests exclusively in healthcare IT and tech-enabled services businesses, partnering with founders and management teams to accelerate growth. The firm describes its approach as combining investment expertise with healthcare operational acumen and a collaborative partnership model, providing strategic guidance, operational support, resources and talent to portfolio companies.
Mike Morgan, CEO of Truehelm portfolio company CollabDocs and former CEO of exited portfolio company Updox, said the firm brings "the industry knowledge, strategic insight, and operational rigor necessary to drive sustainable growth." Truehelm CEO and Partner Dawn Owens said the firm remains committed to supporting founders building healthcare companies and is honored by the trust its partners place in it.
The announcement is one of several recent Inc. Founder-Friendly Investors recognitions issued through Business Wire, including releases from FTV Capital, Nonantum Capital Partners and Hildred. The press release does not disclose fund size, deal values or assets under management.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.